| 产品详情 |
| Edit |   |
|---|
| Antigenic Specificity | PI 3-Kinase p85 beta |
|---|
| Clone | T4 |
|---|
| Host Species | Mouse |
|---|
| Reactive Species | bovine, primate |
|---|
| Isotype | IgG1 |
|---|
| Format | supernatant |
|---|
| Size | 1 ml |
|---|
| Concentration | n/a |
|---|
| Applications | Western Blot, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Frozen. IP: Use at a dilution of 25ul. Not tested in other applications.Optimal dilutions/concentrations should be determined by the end user. |
|---|
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
|---|
| Description | The PI 3-Kinase p85 beta Antibody (T4) from Novus Biologicals is a mouse monoclonal antibody to PI 3-Kinase p85 beta. This antibody reacts with bovine, primate. The PI 3-Kinase p85 beta Antibody (T4) has been validated for the following applications: Western Blot, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Frozen. This is specific for the p85 beta subunit of bovine PI3 kinase |
|---|
| Immunogen | Baculovirus expressed recombinant bovine p85 beta subunit of PI3 kinase. |
|---|
| Other Names | P85B, phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta, phosphatidylinositol 3-kinase regulatory subunit beta, phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta), phosphoinositide-3-kinase, regulatory subunit 2 (beta), phosphoinositide-3-kinase, regulatory subunit 2 (p85 beta), phosphoinositide-3-kinase, regulatory subunit, polypeptide 2 (p85 beta), PI3K regulatory subunit beta, PI3-kinase regulatory subunit beta, PI3-kinase subunit p85-beta, ptdIns-3-kinase regulatory subunit beta, ptdIns-3-kinase regulatory subunit p85-beta |
|---|
| Gene, Accession # | PIK3R2, Gene ID: 5296, Accession: P23726 |
|---|
| Catalog # | NB110-60016 |
|---|
| Price | |
|---|
| Order / More Info | PI 3-Kinase p85 beta Antibody from NOVUS BIOLOGICALS, LLC |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|